SORT1 and neoplasm: Given the current molecular demonstration that exploiting SORT1 function to internalize TH1902 within these CSC further enables to circumvent their chemoresistance phenotype provides the rationale that such therapy may also impact on the tumor microenvironment of the CSC niche.